These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3408666)

  • 1. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus.
    Pasricha JS; Thanzama J; Khan UK
    Br J Dermatol; 1988 Jul; 119(1):73-7. PubMed ID: 3408666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current regimen of pulse therapy for pemphigus: minor modifications, improved results.
    Pasricha JS;
    Indian J Dermatol Venereol Leprol; 2008; 74(3):217-21. PubMed ID: 18583786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-cyclophosphamide pulse therapy for pemphigus.
    Pasricha JS; Khaitan BK; Raman RS; Chandra M
    Int J Dermatol; 1995 Dec; 34(12):875-82. PubMed ID: 8647673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris.
    Pasricha JS; Das SS
    Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
    Jain R; Kumar B
    J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further Studies on Pemphigus Patients Treated with Dexamethasone.
    Pasricha JS; Seetharam KA; Das U
    Indian J Dermatol Venereol Leprol; 1989; 55(2):98-104. PubMed ID: 28128101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kaur S; Kanwar AJ
    Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
    Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
    Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
    Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
    Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
    J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series.
    Kandan S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(4):373-8. PubMed ID: 19584462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy.
    Nayak CS; Ray S; Thombre A; Jain M
    Indian J Dermatol Venereol Leprol; 2014; 80(4):296-9. PubMed ID: 25035352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hiccup--a side-effect of pulse therapy.
    Kanwar AJ; Kaur S; Dhar S; Ghosh S
    Dermatology; 1993; 187(4):279. PubMed ID: 8274787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.